National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 65,928 cases where Vaccine targets HPV (HPV2 or HPV4 or HPV9 or HPVX) and Submission Date on/before '2017-10-31'

Case Details

This is page 26 out of 6,593

Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next


VAERS ID: 267466 (history)  
Form: Version 1.0  
Age: 21.0  
Sex: Female  
Location: Alabama  
Vaccinated:2006-08-28
Onset:2006-09-22
   Days after vaccination:25
Submitted: 2007-04-06
   Days after onset:196
Entered: 2006-11-16
   Days after submission:140
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0689F / 1 UN / IM

Administered by: Private       Purchased by: Private
Symptoms: Band neutrophil percentage decreased, Body temperature increased, Chills, Eosinophil percentage, Epstein-Barr virus antibody negative, Epstein-Barr virus antigen positive, Epstein-Barr virus test negative, Headache, Herpes simplex, Herpes simplex serology positive, Insomnia, Laboratory test abnormal, Lymphocyte percentage, Lymphocyte percentage decreased, Monocyte percentage, Neutrophil percentage decreased, Pain, Pyrexia, Rhinorrhoea, White blood cell count abnormal
SMQs:, Agranulocytosis (broad), Haematopoietic leukopenia (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Ortho Tri Cyclen
Current Illness:
Preexisting Conditions: Medical History: Vaginosis bacterial, yeast infection
Allergies:
Diagnostic Lab Data: body temp 101-103F; clinical seriology test, 10/23/06, positive; serum Epstein Barr 10/23/2006 negative, serum herpes simplex 10/23/06 positive; serum herpes simplex negative; WBC count normal; absolute blood atypical, 10/23/06, 13%, 0-6, high; band neutrophil count, 10/23/06, 5.0%, 0-5; eosinophil count, 10/23/06, 1.0%, 0-5; lymphocyte count, 10/23/06, 32.0%, 15-43; monocyte count, 10/23/06, 7.0%, 5-15; neutrophil count, 10/23/06, 42.0%, 43-75, Low; body temp, 101-103F; white blood cell, 10/23/06, moderate smudge cells; serum Epstein-Barr VCA, 10/23/06, positive; serum Epstein-Barr VCA, 10/23/06, - negative; serum EBNA antibody, 10/23/06, - positive; serum herpes simplex, 10/23/06, - positive; serum herpes simplex 10/23/06, 7.41 X1000 4.8 - 10.8 normal
CDC Split Type: WAES0610USA14581

Write-up: Information has been received from a Certified Medical Assistant concerning a 21 year old female patient with a history of bacterial vaginosis and yeast infections who on 28 Aug 2006 was vaccinated IM in left deltoid with her first dose of Gardisil vaccine (yeast) lot #653736/0689F. Concomitant therapy included ethinyl estradiol/norgestimate (Ortho Tri-Cyclen). ON 22 Sep 2006 the patient developed fever, which she reported was "off and on". She described the fever as spiking at night after 6-7pm. Her fevers would reach 101-103 F and they resolved with rest plus the use of acetaminophen (Tylenol). After " a couple days or so", the fevers would reappear. Other symptoms included headache, hot and cold chill, body aches, waking in the night. The CMA stated that the patient reported these symptoms to the physician''s office on 23 Oct 2006. Laboratory tests performed on that date included HSV(herpes simplex virus) IGG type 1 (positive); HSV IGG type 2 (negative); and EBV(Epstein-Barr virus) (negative). It was reported "EBN was positive". Also reported was "sed rate and CBC=white blood cell count was normal". The patient was to be seen the following week to determine whether the fevers continued. Follow up information indicated that when the patient was seen on 30 Oct 2006 she received a second dose of Gardisil. The CMA noted that the patient was fine "so far". Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2006. Information has been received from a Certified Medical Assistant concerning a 21 year old female patient with a history of bacterial vaginosis and yeast infections who on 28-AUG-2006 was vaccinated IM in left deltoid with her first dose of GARDASIL lot #653736/0689F. Concomitant therapy included ORTHO TRI-CYCLEN. On 22-SEP-2006 the patient developed fever, which she reported was "off and on". She described the fever as spiking at night after 6-7 p.m. Her fevers would reach 101-103 F and they resolved with rest plus the use of TYLENOL. After "a couple days or so", the fevers would reappear. Other symptoms included headache, hot and cold chills, body aches, and waking in the night. The CMA stated that the patient also took unspecified allergy and cold medicine for a runny nose during the past month. The patient reported these symptoms to the physician''s office on 23-OCT-2006. Laborary tests performed on that date included HSV (herpes simplex virus) IGG type 1 (positive); HSV IGG type 2 (negative) ; and EBV (Epstein-Barr virus) (negative). It was reported "EBN was positive". Also reported was "sed-rate and CBC = white blood cell count was normal". The patient was to be seen the following week to determine whether the fevers continued. Follow up information indicated that when the patient was seen on 30-OCT-2006 she received a second dose of GARDASIL. The CMA noted that the patient was fine "so far". Additional follow up information has been received from a physician concerning the 21 year old black female student who on 28-AUG-2006 at 11:30 a.m. was vaccinated IM in left arm with her first dose of GARDASIL lot #653736/0689F. The physician reported that the patient made an appointment on 23-OCT-2006 with fever X 2 weeks. Diagnostic laboratory tests were performed, including positive EBNA (Epstein-Barr virus nuclear antigen antibody) and EBV VCA IgG (Epstein-Barr viral capsid antigen immunoglobulin G antibody), which indicated past infection. EBV VCA IgM (Epstein-Barr viral capsid antigen immunoglobulin M antibody) was negative (see laboratory data section for other results). The patient had mononucleosis. The physician indicated she had recovered. Additional information is not expected.


VAERS ID: 267467 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: New York  
Vaccinated:2006-10-26
Onset:2006-10-26
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:19
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Blister, Oral mucosal blistering, Swelling
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (broad), Angioedema (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA14848

Write-up: Information has been received from a physician concerning a female patient who on 26-OCT-2006 was vaccinated IM with a first dose of GARDASIL. On 26-OCT-2006 the patient experienced swelling as well as blisters in mouth and on the neck. Unspecified medical attention was sought. At the time of this report, the patient''s outcome was unknown. No product quality complaint was involved. Additional information has been requested.


VAERS ID: 267468 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Loss of consciousness
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA14937

Write-up: Information has been received from a physician concerning a female teenager who was vaccinated IM with a first dose of Gardisil. The patient "passed out" when she received the injection. The physician is planning to give the doses as recommended. Unspecified medical attention was sought. Shortly after vaccination, the patient recovered. No product quality complaint was involved. Additional information is not expected.


VAERS ID: 267469 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: California  
Vaccinated:2006-10-23
Onset:2006-10-23
   Days after vaccination:0
Submitted: 2007-04-06
   Days after onset:165
Entered: 2006-11-16
   Days after submission:140
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Private       Purchased by: Private
Symptoms: Body temperature increased, Mononucleosis syndrome, Pain, Pain in extremity, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: body temp 10/23/06 102, body temp 10/26/06 100.
CDC Split Type: WAES0610USA14943

Write-up: Information has been received from a physician concerning an 18 year old female who on 23 Oct 2006 was vaccinated with 0.5mL of Gardisil (yeast). There were no concomitant medications reported. On 23 Oct 2006, the patient developed a high fever of 102 degrees after receiving shot of Gardisil. The temperature continued for three days and was now noted at 100 degrees. The patient also developed achy legs. The patient sought unspecified medical attention. At the time of this report, the patient had not recovered from the events. Additional information has been requested. This is in follow-up to report (s) previously submitted on 11/14/2006. Initial and follow up information has been received from a physician concerning an 18 year old white female student who on 23-OCT-2006 was vaccinated intramuscularly in the arm with the first 0.5 mL dose of GARDASIL. There were no concomitant medications reported. On 23-OCT-2006, the patient developed a high fever of 102 degrees after receiving shot of GARDASIL. The temperature continued for three days and on 26-OCT-2006 was noted at 100 degrees. The patient also developed achy legs. On 30-OCT-2006, that next week, the patient was diagnosed with mononucleosis. At the time of this report, the outcome of the events were unknown. Additional information has been requested.


VAERS ID: 267470 (history)  
Form: Version 1.0  
Age: 30.0  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Amenorrhoea, Incorrect dose administered
SMQs:, Fertility disorders (broad), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA14944

Write-up: Information has been received from a physician assistant in her "late thirties" who on an unspecified date was vaccinated intramuscularly with the first dose of Gardisil vaccine (yeast). The physician assistant reported that she did not get her period the first month after the Gardisil vaccine. It was unknown if the patient sought unspecified medical attention. At the time of this report, the outcome of the events were unknown as " the patient was not due yet for her next menstrual cycle". Additional information has been requested.


VAERS ID: 267471 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Syncope vasovagal
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: WAES0610USA14972

Write-up: Information has been received from a nurse practitioner concerning a patient who was vaccinated with a dose of Gardisil vaccine (yeast). The nurse practitioner reported that the patient "experienced a vasovagal reaction and felt woozy and fainted within 5 minutes of the injection." At the time of the report, the patient''s outcome was unknown. Additional information has been requested.


VAERS ID: 267472 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2006-10-25
Onset:2006-10-27
   Days after vaccination:2
Submitted: 2006-11-14
   Days after onset:18
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Dizziness, Laboratory test abnormal, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Allergies:
Diagnostic Lab Data: body temp 10/27/06 -about 99
CDC Split Type: WAES0610USA15118

Write-up: Information has been received from a physician concerning a "15 or 16 year old" female who on approximately 25 Oct 2006 or 26 Oct 2006 was vaccinated intramuscularly in the deltoid with Gardisil. On approximately 27 Oct 2006, the patient developed a low grade fever of about 99 and dizziness. The patient sought unspecified medical attention. At the time of this report, the outcome of the events were unknown. Additional information has been requested.


VAERS ID: 267473 (history)  
Form: Version 1.0  
Age: 71.0  
Sex: Female  
Location: Illinois  
Vaccinated:2006-10-31
Onset:2006-10-31
   Days after vaccination:0
Submitted: 2006-11-14
   Days after onset:14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Vaccination complication
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness:
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0610USA15293

Write-up: Information has been received from a registered nurse concerning a female (age not reported) with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 31-OCT-2006, the patient was vaccinated intramuscularly with GARDASIL. There were no concomitant medications reported. Subsequently, the patient experienced a cut which was less than 1/4 inch when the syringe was pulled out from the patient. It was reported that the patient had received the full dose. The patient sought unspecified medical attention. The registered nurse reported that the cut was very minor. At the time of this report, the patient was recovering from the events. Additional information has been requested.


VAERS ID: 267474 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2006-11-14
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Dizziness, Dyspnoea, Tension, Throat tightness
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Anticholinergic syndrome (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Vestibular disorders (broad), Hypersensitivity (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: Adverse event
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES0610USA15327

Write-up: Information has been received from a physician concerning a female age "14 or 15 years old" who on an unspecified date was vaccinated with the first dose of 0.5 ml of GARDASIL. After vaccination, the patient felt faint. It was reported that the patient felt dizzy, had difficulty breathing (also reported as "had a short of breath feeling"), felt like her throat was closing and looked tense. Her lungs were clear, there was no wheezing, no signs or symptoms of swelling, no facial or eye swelling and her blood pressure was stable. The physician reported that she thought this looked like a "slight reaction." The patient was given diphenhydramine hydrochloride (BENADRYL) as a precaution. The physician reported that the events were resolving that same day. It was reported that the patient "experienced similar symptoms not relating to vaccines and felt the symptoms may have been more panic driven than anything else." At the time of this report, the patient had recovered from the events (date unknown). The physician reported that she did not feel that the treatment with diphenhydramine hydrochloride (BENADRYL) was needed to prevent serious criteria and did not feel that this experience was life-threatening to the patient. Additional information has been requested.


VAERS ID: 267475 (history)  
Form: Version 1.0  
Age: 26.0  
Sex: Female  
Location: New York  
Vaccinated:2006-10-24
Onset:2006-10-25
   Days after vaccination:1
Submitted: 2006-11-14
   Days after onset:20
Entered: 2006-11-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 3 UN / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0954F / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Vision blurred
SMQs:, Anticholinergic syndrome (broad), Glaucoma (broad), Lens disorders (broad), Retinal disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0611USA00528

Write-up: Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscularly in the deltoid with the first "1 vial" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, "within a day after immunization," the patient experienced blurry vision in both eyes. The patient sought unspecified medical attention. The patient was told by the physician to come to the office to be evaluated but had not. As of 02-NOV-2006, nine days after receiving GARDASIL, the physician reported that the blurred vision was "getting much better." Additional information has been requested.


Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=26&VAX[]=HPV2&VAX[]=HPV4&VAX[]=HPV9&VAX[]=HPVX&VAXTYPES[]=HPV&SUB_YEAR_HIGH=2017&SUB_MONTH_HIGH=10


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166